Document is current
Any future updates will be listed below
-
Authors
Hawe, Johann S.
Saha, Ashis
Waldenberger, Melanie
Kunze, Sonja
Wahl, Simone
Müller-Nurasyid, Martina
Prokisch, Holger
Grallert, Harald
Herder, Christian
Peters, Annette
Strauch, Konstantin
Theis, Fabian J.
Gieger, Christian
Chambers, John
Battle, Alexis
Heinig, Matthias https://orcid.org/0000-0002-5612-1720
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01ZX1708G)
Singapore National Medical Research Council (NMRC/STaR/0028/2017)
Foundation for the National Institutes of Health (1R01MH109905)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- License Information
-
More Information
Article History
Received: 15 June 2022
Accepted: 11 October 2022
First Online: 7 November 2022
Declarations
:
: The study was carried out in accordance with the Declaration of Helsinki. All KORA participants have given written informed consent and the study was approved by the Ethics Committee of the Bavarian Medical Association. The LOLIPOP study is approved by the National Research Ethics Service (07/H0712/150) and all participants gave written informed consent.
: KORA project agreement for this study was granted under K141/15g. The views expressed are those of the author(s) and not necessarily those of the Imperial College Healthcare NHS Trust, the NHS, the NIHR, or the Department of Health.
: FJT reports receiving consulting fees from Roche Diagnostics GmbH and Cellarity Inc., and ownership interest in Cellarity, Inc. and Dermagnostix. The other authors declare that they have no competing interests.
